Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Interleukin 8 Gene Polymorphism Is Associated with Increased Risk of Nephritis in Cutaneous Vasculitis

MAHSA M. AMOLI, WENDY THOMSON, ALI H. HAJEER, MARIA C. CALVIÑO, CARLOS GARCIA-PORRUA, WILLIAM E.R. OLLIER, and MIGUEL A. GONZALEZ-GAY

ABSTRACT.

Objective.
To assess the influence of interleukin-8 (IL-8), epithelial cell-derived neutrophil-activating peptide (ENA-78), and regulated upon activation normal T cell expressed and secreted (RANTES) gene polymorphisms in the susceptibility and clinical expression of patients fulfilling classification criteria for Henoch-Schönlein purpura (HSP).

Methods. Fifty patients (25 men) from Northwest Spain with primary cutaneous vasculitis classified as HSP according to proposed criteria were studied. All patients were required to have had at least 2 years' followup. Patients and ethnically matched controls were genotyped for IL-8, ENA-78, and RANTES gene polymorphisms.

Results. No allele or genotype differences between patients fulfilling HSP classification criteria and controls were observed for any of the chemokines. However, a significantly increased frequency of allele A of the IL-8 gene polymorphism was found in patients with HSP who developed renal manifestations compared with patients without renal involvement (p = 0.02; pcorr = 0.036). Moreover, the genotype distribution in HSP patients with and without renal involvement showed statistically significant differences (p = 0.02).

Conclusion. In unselected patients with cutaneous vasculitis, carriage of IL-8 allele A influences the susceptibility to renal involvement. (J Rheumatol 2002;29:2367-70)

Key Indexing Terms:

HENOCH-SCHÖNLEIN PURPURA
CC CHEMOKINE
RENAL INVOLVEMENT
CXC CHEMOKINE
IL-8
RANTES
ENA-78


From the ARC Epidemiology Unit, Manchester University Medical School, Manchester, United Kingdom, and the Divisions of Rheumatology and Pediatrics Hospital Xeral-Calde, Lugo, Spain.

M.M. Amoli, MD; W. Thomson. PhD; A.H. Hajeer, PhD; W.E.R. Ollier, PhD, ARC Epidemiology Unit, Manchester University Medical School; M.C. Calviño, MD, Pediatrics Division; C. Garcia-Porrua, MD, PhD; M.A. Gonzalez-Gay, MD, PhD, Rheumatology Division, Hospital Xeral-Calde.

Address reprint requests to Dr. M.A. Gonzalez-Gay, Rheumatology Division, Hospital Xeral-Calde, c) Dr. Ochoa s/n, 27004 Lugo, Spain. E-mail: miguelaggay@hotmail.com

Submitted January 9, 2002; revision accepted May 18, 2002.




Return to November 2002 Table of Contents



© 2002. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.